Moderna, Inc. (NASDAQ:MRNA) shares are trending on Wednesday. The company received a $176 million award from the Rapid Response Partnership Vehicle to boost Influenza vaccine development.
What To Know: On Tuesday, the company announced this award which will aid in the development of an mRNA-based vaccine against the H5 influenza virus.
"mRNA vaccine technology offers advantages in efficacy, speed of development, and production scalability and reliability in addressing infectious disease outbreaks, as demonstrated during the COVID-19 pandemic," said Stéphane Bancel, Chief Executive Officer of Moderna.
Last year the company started a Phase 1/2 study of possible vaccine candidates against the H5 and H7 influenza viruses, results are expected sometime in 2024.
What Else: Moderna's RSV vaccine, on June 28, received positive opinion from the Committee for Medicinal Products for Human Use. This could lead to marketing authorization in the European Union.
How To Buy Moderna Stock
By now you're likely curious about how to participate in the market for Moderna – be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of possible trading platforms here. Many will allow you to buy 'fractional shares,' which allows you to own portions of stock without buying an entire share. For example, some stock, like Berkshire Hathaway, or Amazon.com, can cost thousands of dollars to own just one share. However, if you only want to invest a fraction of that, brokerages will allow you to do so.
In the the case of Moderna, which is trading at $115.99 as of publishing time, $100 would buy you 0.86 shares of stock.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to 'go short' a share of stock by lending you the shares to sell. The process of shorting a stock can be found at this resource. Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading – either way it allows you to profit off of the share price decline.
MRNA Price Action: Moderna stock is trading .98% lower at $115.92 as of Wednesday morning per data from Benzinga Pro.
Image: Photo via Wikimedia Commons
週三,Moderna (納斯達克股票代碼:MRNA)股價走勢。該公司從快速反應夥伴關係機制獲得了1.76億美元的獎勵,以促進流感疫苗的開發。
須知:該公司週二宣佈了這一獎項,該獎項將幫助開發一種基於mRNA的針對H5流感病毒的疫苗。
Moderna首席執行官斯特凡·班塞爾表示:“mRNA疫苗技術在應對傳染病疫情的有效性、開發速度以及生產可擴展性和可靠性方面具有優勢,這在 COVID-19 疫情期間得到了證明。”
去年,該公司啓動了針對H5和H7流感病毒的可能候選疫苗的1/2期研究,預計將在2024年某個時候得出結果。
還有什麼:6月28日,Moderna的呼吸道合胞病毒疫苗獲得了人用藥品委員會的積極評價。這可能會導致歐盟的上市許可。
如何購買 Moderna 股票
到目前爲止,你可能對如何參與Moderna市場感到好奇——無論是購買股票,還是試圖對該公司下注。
購買股票通常通過經紀帳戶完成。您可以在此處找到可能的交易平台列表。許多股票允許您購買 “部分股票”,這使您無需購買整股即可擁有部分股票。例如,某些股票,例如伯克希爾·哈撒韋公司或亞馬遜,僅擁有一股股票可能要花費數千美元。但是,如果您只想投資其中的一小部分,經紀公司將允許您這樣做。
就Moderna而言,截至發佈時的交易價格爲115.99美元,100美元將爲您購買0.86股股票。
如果你想對一家公司下注,這個過程會更加複雜。您需要訪問期權交易平台或經紀商,該經紀人將允許您 “空頭” 一股股票,將股票借給您。可以在此資源中找到做空股票的過程。否則,如果您的經紀人允許您交易期權,您可以買入看跌期權,也可以以高於當前股票交易價格的行使價賣出看漲期權——無論哪種方式,它都允許您從股價下跌中獲利。
MRNA價格走勢:根據Benzinga Pro的數據,截至週三上午,Moderna股票下跌0.98%,至115.92美元。
圖片:照片來自維基共享資源